Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
46,752,465
-
Total 13F shares
-
4,545,482
-
Share change
-
-3,423,576
-
Total reported value
-
$8,586,535
-
Put/Call ratio
-
0.92%
-
Price per share
-
$1.89
-
Number of holders
-
60
-
Value change
-
-$17,552,083
-
Number of buys
-
36
-
Number of sells
-
31
Institutional Holders of Outlook Therapeutics, Inc. - Common Stock, $0.01 par value per share (OTLK) as of Q4 2024
As of 31 Dec 2024 Outlook Therapeutics, Inc. - Common Stock, $0.01 par value per share (OTLK) had 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,545,482 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, STATE STREET CORP, RHUMBLINE ADVISERS, TANG CAPITAL MANAGEMENT LLC, FMR LLC, Woodline Partners LP, and RENAISSANCE TECHNOLOGIES LLC.
This table shows 60 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.